Press release
Chronic Venous Insufficiency Market Size in the 7MM was ~USD 2000 Million in 2023, is expected to grow by 2034 and estimates DelveInsight
Discover Key Insights into the Chronic Venous Insufficiency Market with DelveInsight's In-Depth Report @ Chronic Venous Insufficiency Market Size [https://www.delveinsight.com/sample-request/chronic-venous-insufficiency-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Key Takeaways from the Chronic Venous Insufficiency Market Report
* In November 2024:- TR Therapeutics- The goal of this clinical trial is to learn if TR987 0.1% gel + Standard of Care works better than Standard of Care alone to treat Venous Leg Ulcers (VLUs). It will also provide additional information about the safety of drug TR987 0.1% gel.
* In November 2024:- Medtronic Endovascular- Global, Post-Market, Prospective, Multi-Center, Randomized Controlled Trial of the VenaSeal Trademark Closure System vs. Surgical Stripping or Endothermal Ablation (ETA) for the Treatment of Early & Advanced Stage Superficial Venous Disease.
* In the 7MM, the US accounted for the highest number of prevalent cases of Chronic Venous Insufficiency, with nearly 6.2 million in 2020.
* Among EU4 and the UK, Germany accounted for the highest number of cases of Chronic Venous Insufficiency, followed by UK, whereas Spain occupied the bottom of the ladder.
* According to DelveInsight's epidemiology model for CVD, the C1 stage had the highest diagnosed prevalence in the United States.
* The leading Chronic Venous Insufficiency Companies such as Cardinal Health, Stryker, Boston Scientific Corporation, AngioDynamics, Edward Lifesciences , and others.
* Promising Chronic Venous Insufficiency Therapies such as P -TEV, VenoValve, EnVVe, SONOVEIN , and others.
Stay ahead in the Chronic Venous Insufficiency Therapeutics Market with DelveInsight's Strategic Report @ Chronic Venous Insufficiency Market Outlook [https://www.delveinsight.com/sample-request/chronic-venous-insufficiency-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Chronic Venous Insufficiency Epidemiology Segmentation in the 7MM
* Total Chronic Venous Insufficiency Prevalent Cases
* Chronic Venous Insufficiency Gender-specific Cases
* Chronic Venous Insufficiency Stage-specific Cases
* Chronic Venous Insufficiency Treatable Cases
Download the report to understand which factors are driving Chronic Venous Insufficiency epidemiology trends @ Chronic Venous Insufficiency Prevalence [https://www.delveinsight.com/sample-request/chronic-venous-insufficiency-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Chronic Venous Insufficiency Marketed Drugs
* Venclose System: BD
* ActiTouch: Tactile Medical
Chronic Venous Insufficiency Emerging Drugs
* P-TEV: Verigraft AB
* VenoValve: enVVeno Medical Corporation
Chronic Venous Insufficiency Market Outlook
In the Chronic Venous Insufficiency pipeline among the emerging candidates, SONOVEIN, which is a robotic solution for non-invasive echotherapy treatment using high-intensity focused ultrasound (HIFU) technology. It operates independently without the need for additional accessories such as guide wires, puncture kits, or catheters. The device is being evaluated in a VEINRESET study, which is now transitioning into a 12-month follow-up period, with results projected for release by 2025. The company plans to file the market approval application with the FDA once the study report is available in the second half of 2025.
Get In-Depth Knowledge on Chronic Venous Insufficiency Market Trends and Forecasts with DelveInsight @ Chronic Venous Insufficiency Treatment Market [https://www.delveinsight.com/sample-request/chronic-venous-insufficiency-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Chronic Venous Insufficiency Market Dynamics
The dynamics of the chronic venous insufficiency (CVI) market are anticipated to evolve significantly in the coming years. A notable rise in the prevalent population of CVI, combined with improved accessibility to existing treatments such as compression therapy and antibiotics, presents a considerable market opportunity. The absence of highly effective medications or therapies further underscores this potential, providing room for emerging companies to innovate and make a meaningful impact on patients' lives. Moreover, growing public awareness fosters a favorable environment for the development of new therapeutics, set to drive the CVI market's growth over the long term.
Scope of the Chronic Venous Insufficiency Market Report
* Coverage- 7MM
* Study Period- 2020-2034
* Chronic Venous Insufficiency Companies- Cardinal Health, Stryker, Boston Scientific Corporation, AngioDynamics, Edward Lifesciences, and others.
* Chronic Venous Insufficiency Therapies- P-TEV, VenoValve, EnVVe, SONOVEIN, and others.
* Chronic Venous Insufficiency Therapeutic Assessment: Chronic Venous Insufficiency Current marketed and Chronic Venous Insufficiency Emerging Therapies
* Chronic Venous Insufficiency Market Dynamics: Chronic Venous Insufficiency Market drivers and Chronic Venous Insufficiency Market Barriers
Unlock Strategic Insights with DelveInsight's Comprehensive Chronic Venous Insufficiency Market Report @ Chronic Venous Insufficiency Market Drivers and Barriers [https://www.delveinsight.com/sample-request/chronic-venous-insufficiency-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Table of Content
1. Key Insights
2. Report Introduction
3. CVI Market Overview at a Glance
4. Epidemiology and Market Methodology
5. Executive Summary
6. Key Events
7. Disease Background and Overview
8. Patient Journey
9. Epidemiology and Patient Population
10. Marketed
11. Emerging Drugs
12. Emerging Devices
13. Chronic Venous Insufficiency: Market Analysis
14. Key Opinion Leaders' Views
15. SWOT Analysis
16. Unmet Needs
17. Market Drivers
18. Market Barriers
19. Market Access and Reimbursement
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
23. About DelveInsight
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=chronic-venous-insufficiency-market-size-in-the-7mm-was-usd-2000-million-in-2023-is-expected-to-grow-by-2034-and-estimates-delveinsight]
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/case-study/respiratory-domain-conference-coverage
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Chronic Venous Insufficiency Market Size in the 7MM was ~USD 2000 Million in 2023, is expected to grow by 2034 and estimates DelveInsight here
News-ID: 3771998 • Views: …
More Releases from ABNewswire
Leavitt Peak Press Announces the Release of the Guardians: Paporia Two by F. Tho …
Leavitt Peak Press is proud to announce the release of The Guardians: Paporia Two, the action-packed sequel to The Guardians: Escape from Tirgonia by military veteran and author F. Thomas Jones. This thrilling continuation of the Guardians saga dives deeper into a galactic conflict that pits courage, loyalty, and wisdom against overwhelming odds.
Now in the second year of war with the ruthless Tirogian Empire, The Guardians face their greatest challenge…
Jiaropack Expands Global Footprint and U.S. Manufacturing to Strengthen Supply C …
Image: https://www.abnewswire.com/upload/2025/10/e8885cfe8ab28873224866f01a36a3fa.jpg
California, USA - Jiaropack, a brand of Global Store Supply, Inc., a global leader in packaging, industrial, and shipping materials, today announced a major expansion of its U.S. manufacturing and logistics network to further enhance supply chain stability and nationwide delivery efficiency, providing faster and more reliable products and services to customers worldwide.
To enhance supply chain security and consistent product delivery, Jiaropack has recently purchased several Texas-based plastic product…
Clostridioides Difficile Infection Market Size in the 7MM was ~USD 500 million i …
DelveInsight's "Clostridioides Difficile Infection Market Insights, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of the Clostridioides Difficile Infection, historical and forecasted epidemiology as well as the Clostridioides Difficile Infection therapeutics market trends in the US, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan.
Discover Key Insights into the Clostridioides Difficile Infection Market with DelveInsight's In-Depth Report @ Clostridioides Difficile Infection Treatment Market Size…
Triple Negative Breast Cancer Market Set for Robust Growth Through 2034Innovativ …
Driven by rise of immunotherapies, antibody-drug conjugates, and precision-targeted approaches, TNBC market is projected to expand from USD 4.7 billion in 2025 to USD 7.1 billion by 2034, marking a CAGR of 4.7% across the 7MM. Leading players like AstraZeneca, Pfizer, Gilead Sciences, BioNTech, Astellas Pharma are at forefront, advancing next-generation therapies such as ADC platforms, checkpoint inhibitors, and novel vaccines that aim to improve survival outcomes and redefine patient…
More Releases for Venous
States Venous Stents Market Projected to Witness Expansion with Rising Incidence …
States Venous Stents Market Overview
The States Venous Stents Market is expected to grow from USD 1.3 billion in 2025 to USD 2.4 billion by 2032, registering a CAGR of 8.9%.
Coherent Market Insights is pleased to release its latest States Venous Stents Market research report, offering an in-depth analysis of the U.S. States Venous Stents Market Landscape from 2025 to 2032. This report delivers reliable projections across national and regional levels,…
Venous Stent Market Grows with Rising Cases of Chronic Venous Disorders | Boston …
Venous Stent Market Overview
The venous stent market is anticipated to grow from USD 0.6 billion in 2025 to USD 1.3 billion by 2032, exhibiting a CAGR of 10.3% during the forecast period.
Coherent Market Insights is proud to announce the release of its latest market research report, providing a comprehensive analysis of the Venous Stent Market Landscape from 2025 to 2032. This report delivers precise forecasts across global, regional, and country…
Major Force in the Venous Thromboembolism Market 2025: Impact Of Healthcare Infr …
How Will the Venous Thromboembolism Market Grow, and What Is the Projected Market Size?
Over the past few years, the venous thromboembolism market has experienced a steady increase in its size. It's projected to expand from $2.44 billion in 2024 to $2.55 billion in 2025, rising at a compound annual growth rate (CAGR) of 4.4%. The growth during the historic period can be credited to an increasing elderly population, progress in…
Venous Catheter Market Size 2024 to 2031.
Market Overview and Report Coverage
A venous catheter is a small, flexible tube inserted into a vein for medical purposes such as accessing the bloodstream for medications, fluids, or blood sampling. The venous catheter market is expected to witness significant growth in the coming years, with a projected CAGR of 6.30% during the forecasted period.
The current outlook for the venous catheter market is positive, driven by factors such as…
Venous Skin Ulcer Treatment Market : Lucrative Opportunities
Venous Skin Ulcer Treatment Market: Introduction
According to the report, the global venous skin ulcer treatment market was valued at US$ 2.6 Bn in 2019. It is expected to expand at a CAGR of ~5% during the forecast period from 2020 to 2030. Various advanced technologies and treatment options are presently available for venous skin ulcer. The treatment for skin ulcer include different therapies such as compression therapy, advanced wound dressings,…
Increasing Prevalence of Venous Thromboembolism to Augment Growth of the Venous …
Venous thromboembolism (VTE) is the formation of blood clots in the bloodstream. Two main types of venous thromboembolism are pulmonary embolism and deep vein thrombosis. The formation of blood clots in a deep vein is called deep vein thrombosis, while the deep vein thrombosis formed breaks the clot and travels to the lungs, known as pulmonary embolism.
Sample Copy Of Report @ https://www.coherentmarketinsights.com/insight/request-sample/188
Pulmonary embolism occurs in almost one-third of patients…
